ScreenerHero

ADTXAditxt, Inc.

NAS · US · Healthcare · Biotechnology · aditxt.com
0.0050USD+138.10%Mkt Cap: 4.99M $P/E: —

Aditxt, Inc. focuses on discovery and development of biopharmaceutical products. The company develops AditxtScore and FlowSpot that enable individuals to understand, manage, and monitor their immune profiles in order to …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap4.99M $
Enterprise Value2.07M $
Revenue (TTM)14.34K $
Gross Profit268 $
Net Income (TTM)-41.71M $
Revenue/Share0.3710 USD
Last Price0.0050 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees26
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA-0.11
EV/Revenue144.33
P/S139.23
P/B-0.00
EPS (TTM)-1380.80
EPS (Forward)-11.29
52W Range
0.00200% of range28801.44
52W High28801.44 USD
52W Low0.0020 USD
Profitability
Gross Margin8.39%
Oper. Margin-35873.53%
EBITDA Margin0.00%
Profit Margin-1305608.79%
ROE-743.61%
ROA-252.56%
Growth
Revenue Growth1094.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-25.69M $
CapEx (TTM)13.74K $
FCF Margin-86119.09%
FCF Yield-247.42%
Net Debt3.96M $
Net Debt/EBITDA-0.22
Balance Sheet
Debt/Equity0.54
Current Ratio0.06
Quick Ratio0.02
Book Value/Sh-861.4280 USD
Cash/Share0.3300 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:27
Split DateMay 18, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.997.98M
Float181.61K
Insiders0.06%
Institutions0.05%
Short Interest
Short Ratio0.0d
Short % Float34.50%
Short % Out.34.50%
Shares Short281.50K
Short (prev mo.)3.39K
Technical
SMA 500.0056 (-10.7%)
SMA 200179.98 (-100.0%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)14.05M
Avg Vol (10d)10.21M
Technical Indicators
RSI (14)15.0
MACD-0.1108
MACD Signal-0.1625
MACD Hist.+0.0516
BB Upper0.0041 USD
BB Middle0.0028 USD
BB Lower0.0015 USD
BB Width90.82%
ATR (14)0.0292 USD
Vol Ratio (20d)9.34x